IL-6 in inflammation, immunity, and disease.
By Toshio Tanaka, M. Narazaki, T. Kishimoto. Cold Spring Harbor Perspectives in Biology, 2014
4,456 citations recorded by the source corpus.
Subfields: Hematology, Oncology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/2b775e62648729abe21303cea7d5d0863af84612
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Sonnenburg
- H. Wastyk
- Justin L. Sonnenburg
- Gabriela K. Fragiadakis
- Dalia Perelman
- D. Dahan
- Carlos G. Gonzalez
- Bryan D. Merrill
Citations in the corpus
- Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy (2022, background): “Furthermore, the release of IL-6 from pyroptotic cells contributes to the adaptive response by increasing cell trafficking, differentiation, and antibody production of CD8+ T cells, inhibiting Tregs differentiation and macrophages death.(221,222) Interestingly, it is increasingly recognized that mem”
- Gut Microbiota-Targeted Diets Modulate Human Immune Status (2020, positive): “elevated in several chronic inflammatory conditions such as rheumatoid arthritis, type-2 diabetes, and chronic stress, and is a commonly used metric of inflammation (reviewed in (Tanaka et al., 2014)).”
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies (2020, background): “Except for STAT1, STAT3, and STAT5 in the splenocytes of SLE-prone MRL/lpr mice could be inhibited by SM934, an artemisinin derivative (122).”
- The Gut Microbiota and Inflammation: An Overview (2020, background): “* Contrasting mechanisms demonstrate that this cytokine is both involved in pro- and anti-inflammatory processes [101,103].”